Shengwu Liu, PhD
Instructor
|
Shengwu's scientific interests focus on KRAS signaling in cancer and its associated interaction with tumor microenvironment. He is currently working to identify novel vulnerabilities targeting KRAS itself or the tumor immunity using saturation mutagenesis and single-cell RNAseq. He aims to develop novel treatment strategies against KRAS mutant cancers.
Contact: Shengwu_Liu@dfci.harvard.edu |